CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Clinical and Genetic Characteristics of BRCA1/2 Mutation in Korean Ovarian Cancer Patients: A Multicenter Study and Literature Review
Byung Su Kwon, Jung Mi Byun, Hyun Joo Lee, Dae Hoon Jeong, Tae Hwa Lee, Kyung-Hwa Shin, Dong Soo Suh, Ki Hyung Kim
Cancer Research and Treatment. 2019;51(3):941-950.   Published online 2018 October 8    DOI: https://doi.org/10.4143/crt.2018.312

Excel Download

Clinical and Genetic Characteristics of BRCA1/2 Mutation in Korean Ovarian Cancer Patients: A Multicenter Study and Literature Review
Cancer Research and Treatment. 2019;51(3):941-950   Crossref logo
Link1 Link2 Link3

Real-World Experience of Olaparib Maintenance in High-Grade Serous Recurrent Ovarian Cancer Patients with BRCA1/2 Mutation: A Korean Multicenter Study
Journal of Clinical Medicine. 2019;8(11):1920   Crossref logo
Link1

Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic modifiers
Journal of Internal Medicine. 2012;271(4):331-343   Crossref logo
Link1 Link2

The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers
Breast Cancer Research and Treatment. 2009;121(3):639-649   Crossref logo
Link1 Link2 Link3

Clinical characteristics of ovarian cancer relapse in BRCA1/2 germ-line mutation carriers and non-carriers
Annals of Oncology. 2018;29:viii354   Crossref logo
Link1 Link2 Link3

Uptake of Family-Specific Mutation Genetic Testing Among Relatives of Patients with Ovarian Cancer with BRCA1 or BRCA2 Mutation
Cancer Research and Treatment. 2021;53(1):207-211   Crossref logo
Link1 Link2 Link3

Difference in Risk of Breast and Ovarian Cancer According to Putative Functional Domain Regions in Korean BRCA1/2 Mutation Carriers
Clinical Breast Cancer. 2018;18(5):362-373.e1   Crossref logo
Link1 Link2

When to Consider Risk-Reducing Mastectomy in BRCA1/BRCA2 Mutation Carriers with Advanced Stage Ovarian Cancer: a Case Study Illustrating the Genetic Counseling Challenges
Journal of Genetic Counseling. 2017;26(6):1173-1178   Crossref logo
Link1 Link2 Link3

Rucaparib in patients presenting a metastatic breast cancer with Homologous Recombination Deficiency, without germline BRCA1/2 mutation
. 2021;   Crossref logo
Link1 Link2

New Germinal Mutation of BRCA1 gene (c.829_832delAATA) in a Polish Patient with Breast/Ovarian Cancer
. 2020;   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.